适合大型医院、医疗机构作为相应感染病症状/症候群的常备诊疗手段,也可在群体性突发事件/大流行病(如 COVID-19)中发挥其操作简单、检测高效的优势。 罗氏通过收购GenMark将该平台产品纳入其麾下,扩充了其分子诊断版图。该平台也将持续发展,以应对更...
适合大型医院、医疗机构作为相应感染病症状/症候群的常备诊疗手段,也可在群体性突发事件/大流行病(如 COVID-19)中发挥其操作简单、检测高效的优势。 罗氏通过收购GenMark将该平台产品纳入其麾下,扩充了其分子诊断版图。该平台也将持续发展,以应对更多病症的快速检测。 注: 1. 参考专利:US11300578 2. 图片和视频...
适合大型医院、医疗机构作为相应感染病症状/症候群的常备诊疗手段,也可在群体性突发事件/大流行病(如 COVID-19)中发挥其操作简单、检测高效的优势。 罗氏通过收购GenMark将该平台产品纳入其麾下,扩充了其分子诊断版图。该平台也将持续发展,以应对更多病症的快速检测。 注: 1. 参考专利:US11300578 2. 图片和视频...
GenMarkePlexPanelsSARS-CoV-2The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) ...
Reduction in pre- and post-analytical steps improve time to results and minimizes the risk of avoidable error Thecobas®eplexsystem supports the interface works with HL7, ASTM and CSV, XML, TXT (non-standard) cobas eplex software benefits ...
5 US hospitals GenMark clinical study Potula* Weighted average Number of samples (n) 15793 1979 2746 20518 cobas® eplex BCID Panel 94.3% 93.6% 97.8% 94.6% Competitor 1 BCID 84.3% 86.6% 89.6% 85.3% Competitor 1 BCID v2 86.8% 89.1% 90.4% 86.4% Competitor 2 BC 83.1% 83.0% 85.5% 83....
The performance of the new ePlex Respiratory Pathogen (RP) panel (GenMark Diagnostics) for the simultaneous detection of 19 viruses (influenza A virus; inf... NE Babady,MR England,KL Jurcic Smith,... - 《Journal of Clinical Microbiology》 被引量: 8发表: 2018年 ...
200. Prospective Evaluation of the GenMark Dx ePlex Blood Culture Identification Gram Positive PanelBACKGROUND. The ePlex BCID Gram-Positive (GP) panel utilizes electrowetting technology to detect the most common causes of GP bacteremia (20 targets) and 4 antimicrobial resistance genes in positive ...
Implementation of the GenMark ePlex BCID-GP panel reduced time to targeted antibiotic therapy by nearly 24 hours. Clinical outcomes including hospital LOS and all-cause 30-day mortality did not show a statistical difference, although analysis of a larger sample size is necessary to appropriately ...
The GenMark Dx ePlex BCID Gram-Negative (GN) panel utilizes electrowetting technology to detect the most common causes of GN bacteremia (21 targets) and 6 antimicrobial resistance (AMR) genes from positive blood culture (BC) bottles. Rapid detection of extended spectrum 尾-lactamases (ESBL: CTX...